申请人:GRUENENTHAL GMBH
公开号:US20220127264A1
公开(公告)日:2022-04-28
The invention relates to compounds according to general formula (I),
which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.